EQA reagent RQ9111
solutionfor therapeutic drug monitoringlyophilized

EQA reagent - RQ9111 - Randox Laboratories - solution / for therapeutic drug monitoring / lyophilized
EQA reagent - RQ9111 - Randox Laboratories - solution / for therapeutic drug monitoring / lyophilized
Add to favorites
Compare this product

fo_shop_gate_exact_title

Characteristics

Type
solution
Applications
for EQA, for therapeutic drug monitoring
Format
lyophilized
Tested parameter
digoxin, for drugs, lithium, valproic acid

Description

The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter. Accredited to ISO/IEC 17043 Lyophilised for enhanced stability 100% human serum Bi-weekly reporting Submit results and view reports online via RIQAS.Net Register up to five instruments at no extra cost Weighed in values reported for each parameter Parameters Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digoxin, Ethosuximide, Gentamicin, Lithium, Methotrexate, Paracetamol, Phenobarbital, Phenytoin, Primidone, Salicylic acid, Theophylline, Tobramycin, Valproic acid and Vancomycin"

Exhibitions

Meet this supplier at the following exhibition(s):

ArabLab 2025
ArabLab 2025

23-25 Sep 2025 dubai (United Arab Emirates) Hall H2 - Stand B10

  • More information

    Other Randox Laboratories products

    EQA

    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.